9α-Hy­droxy-12-{[4-(4-hy­droxy­phen­yl)piperazin-1-yl]meth­yl}-4,8-dimethyl-3,14-dioxatri­cyclo­[9.3.0.02,4]tetra­dec-7-en-13-one

Loubidi, M.; Benharref, A.; El Ammari, L.; Saadi, M.; Berraho, M.

doi:10.1107/S1600536814007430

Acta Crystallographica Section E
Acta Crystallographica
Section E CRYSTALLOGRAPHIC COMMUNICATIONS

IUCr IT WDC

home archive editors for authors for readers submit open access

view article

Figure 1 The molecular structure of the title compound with the atom-labelling scheme. Displacement ellipsoids are drawn at the 30% probability level. H atoms are represented as small spheres of arbitrary radii. For clarity only the major disorder components of the disordered C21 C22 and O5 atoms are shown.

CRYSTALLOGRAPHIC
COMMUNICATIONS

ISSN: 2056-9890

Volume 70| Part 5| April 2014| Pages o530-o531

doi:10.1107/S1600536814007430

Follow Acta Cryst. E

Search IUCr Journals		doi		Advanced search
Author		volume	page